![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
Sep. 17th, 2010 at 12:37 PM
Bacteria containing a gene that allows for the production of the Klebsiella pneumoniae carbapenamase enzyme that renders carbapenam antibiotics useless have "now been reported in more than half of the states," according to CDC's Arjun Srinivasan. Doctors are expressing their worry about this particular bug because carbapenam antibiotics are considered the last-resort treatment for infections that cannot be treated by other drugs. "We're in the same position with KPCs as we were with staph aureus 15 years ago, except that the pharmaceutical industry isn't rushing to produce new drugs," one expert said. USA TODAY (9/17)
**
Improved understanding of mental illness doesn't lift social stigma
More Americans are understanding the biological roots of mental disorders such as depression and schizophrenia, but that does not translate to more acceptance of patients with such illnesses, a study showed. "If people think it is biological or genetic, they are seeing people in a different 'class' and with some permanence that could impact their 'family line.' We need to think about new ways to think about 'difference' and tolerance," the lead researcher said. Reuters (9/16)